Drug intelligence / Profile preview

MyoBeads

Development stage
Preclinical
Lead developer
Regencor
Modality
Recombinant Proteins and Enzymes, Nanoparticles → Drug Delivery Systems
Administration
Intracoronary
01

Overview

MyoBeads is a **sustained-release biodegradable microparticle biologic** being developed by Regencor for patients with acute myocardial infarction undergoing percutaneous coronary intervention. The product contains **recombinant non-glycosylated human follistatin-like 1**, specifically the **hypoglycosylated FSTL1 variant**, formulated as microspheres that are infused through the infarct-related artery during PCI using the interventional catheter. Its intended mechanism is localized delivery of FSTL1 to the infarct zone to drive controlled cardiomyocyte proliferation, regenerate cardiac muscle, improve ventricular contractility, reduce scar formation, and prevent progression to heart failure after myocardial infarction.

Brand names
MyoBeads
Other names
hgFSTL1 sustained release microsphere formulationhgFSTL-1 sustained release microsphere formulationhgFSTL 1 sustained release microsphere formulationrecombinant non-glycosylated human FSTL1 sustained release microsphere formulation

Beyond the preview

Go deeper on MyoBeads.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MyoBeads.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call